Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Deuson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Health Care Management Science|August 1, 2000
An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot studyS H Jacobson, E C Sewell, R Deuson, et al.
American Journal of Epidemiology|November 29, 2001
Rotavirus vaccine and intussusception: how much risk will parents in the United States accept to obtain vaccine benefits?S L Sansom, L Barker, P S Corso, et al.
Archives of Pediatrics & Adolescent Medicine|August 30, 2001
Economic analysis of a child vaccination project among Asian Americans in Philadelphia, PaR R Deuson, K G Brodovicz, L Barker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatmentBrigitte Bloechl-Daum, Robert R Deuson, Panagiotis Mavros, et al.
Pediatrics|October 3, 2002
Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysisFangjun Zhou, Kristine M Bisgard, Hussain R Yusuf, et al.
Journal of Medical Economics|December 6, 2011
Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescueM Iskedjian, A T Tinmouth, D M Arnold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centersA Ihbe-Heffinger, B Ehlken, R Bernard, et al.
American Journal of Hematology|March 31, 2012
Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of careDavid J Kuter, Susan D Mathias, Mathias Rummel, et al.
Vaccine|October 31, 1998
Addressing the challenges to immunization practice with an economic algorithm for vaccine selectionB G Weniger, R T Chen, S H Jacobson, et al.
American Journal of Public Health|November 30, 1999
The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulationR R Deuson, E J Hoekstra, R Sedjo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Health Care Management Science|August 1, 2000
An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot studyS H Jacobson, E C Sewell, R Deuson, et al.
American Journal of Epidemiology|November 29, 2001
Rotavirus vaccine and intussusception: how much risk will parents in the United States accept to obtain vaccine benefits?S L Sansom, L Barker, P S Corso, et al.
Archives of Pediatrics & Adolescent Medicine|August 30, 2001
Economic analysis of a child vaccination project among Asian Americans in Philadelphia, PaR R Deuson, K G Brodovicz, L Barker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatmentBrigitte Bloechl-Daum, Robert R Deuson, Panagiotis Mavros, et al.
Pediatrics|October 3, 2002
Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysisFangjun Zhou, Kristine M Bisgard, Hussain R Yusuf, et al.
Journal of Medical Economics|December 6, 2011
Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescueM Iskedjian, A T Tinmouth, D M Arnold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centersA Ihbe-Heffinger, B Ehlken, R Bernard, et al.
American Journal of Hematology|March 31, 2012
Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of careDavid J Kuter, Susan D Mathias, Mathias Rummel, et al.
Vaccine|October 31, 1998
Addressing the challenges to immunization practice with an economic algorithm for vaccine selectionB G Weniger, R T Chen, S H Jacobson, et al.
American Journal of Public Health|November 30, 1999
The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulationR R Deuson, E J Hoekstra, R Sedjo, et al.
Pageof 2